Compositions and methods for modulating TLR14 activity

Details for Australian Patent Application No. 2007313151 (hide)

Owner Wyeth Opsona Therapeutics, Ltd.

Inventors Mcormack, William John; Gao, Ying; Lin, Lih-Ling; Seidl, Katherine; Dunne, Aisling

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007313151

PCT Pub. Number WO2008/048670

Priority 0620695.7 18.10.06 GB

Filing date 18 October 2007

Wipo publication date 24 April 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/048670 Priority application(s): WO2008/048670

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007313155-Materials leading to improved dental composites and dental composites made therefrom

2007313149-Novel inhibitors of chymase